查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585722

血糖试纸市场：按技术、分销管道划分 - 全球预测 2025-2030 年

Blood Glucose Test Strips Market by Technology (Channel Technology, Wicking Technology), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血糖试纸市值为59.1亿美元，预计2024年将达到63.7亿美元，复合年增长率为7.86%，预计到2030年将达到100.5亿美元。

血糖试纸在糖尿病管理中至关重要，它使个人能够有效监测自己的血糖值。此市场范围主要涵盖医疗保健应用，包括糖尿病患者的个人使用和临床环境中的使用。由于这些试纸对于糖尿病的诊断和管理至关重要，因此它们具有广泛的最终用途，从医院、诊所到居家医疗场所。由于生活型态的改变、人口老化和肥胖增加等因素，全世界糖尿病盛行率不断上升，证明了对血糖试纸的需求。关键的成长要素包括技术进步，例如无编码试纸的开发、健康意识的提高以及政府促进糖尿病治疗的措施。此外，在新兴市场扩大医疗基础设施也提供了巨大的成长潜力。然而，市场扩张受到定价压力、报销问题和严格监管标准等因素的阻碍。此外，与连续血糖监测系统的竞争也是一个问题。创新易于使用、侵入性较小的检测解决方案的机会比比皆是，以提高患者的依从性并满足日益增长的个人化医疗需求。公司可以投资开发具有先进分析功能的试纸，并与数位健康平台集成，以进行即时监控和资料分析。与数位健康公司合作提供全面的糖尿病管理解决方案还可以开启新的收益来源。市场严重偏向创新和研究，这表明将人工智慧和物联网整合到产品中有可能彻底改变疾病管理。透过相关人员的参与了解患者的需求和监管要求对于永续成长至关重要。企业应注重策略伙伴关係和收购，以有效进入新市场，确保创新和成本效率之间的平衡，以保持市场竞争力。

主要市场统计
基准年[2023] 59.1亿美元
预测年份 [2024] 63.7亿美元
预测年份 [2030] 100.5亿美元
复合年增长率（%） 7.86%

市场动态：快速发展的血糖试纸市场的关键市场洞察

供需的动态交互作用正在改变血糖试纸市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 随着糖尿病患者数量的增加，需要有效的方法来检测血糖值的快速变化
    • 糖尿病预防保健意识
    • 糖尿病用品购买和使用指南
  • 市场限制因素
    • 糖尿病管理成本高
  • 市场机会
    • 线上产品普及
    • 亚洲新兴经济体因糖尿病人口庞大和医疗费用上涨而具有潜力
  • 市场挑战
    • 血糖试纸准确度不够

波特五力：驾驭血糖试纸市场的策略工具

波特的五力框架是了解血糖试纸市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血糖试纸市场的外部影响

外部宏观环境因素在塑造血糖试纸市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血糖试纸市场竞争格局

血糖试纸市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵血糖试纸市场供应商的绩效评估

FPNV定位矩阵是评估血糖试纸市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了血糖试纸市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血糖试纸市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着糖尿病患者数量的增加，需要一种有效检测血糖值快速变化的方法。
      • 糖尿病预防保健意识
      • 糖尿病用品购买和使用指南
    • 抑制因素
      • 糖尿病管理成本高昂
    • 机会
      • 线上产品可用性快速增加
      • 亚洲新兴经济体因糖尿病人口众多和医疗费用上涨而具有潜力
    • 任务
      • 血糖试纸缺乏准确性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章血糖试纸市场：依技术分类

  • 通路技术
  • 芯吸技术

第七章血糖试纸市场：依通路

  • 医院药房
  • 网路药房
  • 零售药房

第八章美洲血糖试纸市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太血糖试纸市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 血糖检测试纸市场欧洲、中东和非洲

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • A. Menarini Diagnostics srl
  • AgaMatrix, Inc.
  • B. Braun Medical Ltd
  • Bayer AG
  • BioSensors, Inc.
  • F. Hoffmann-La Roche Ltd
  • GlucoRx Limited
  • i-SENS Inc
  • LifeScan, Inc.
  • National Diagnostic Products Pty Ltd
  • Nipro Diagnostics UK Limited
  • PHC Holdings Corporation
  • Spirit Healthcare
  • TaiDoc Technology Corporation
  • Universal Biosensors Group
Product Code: MRR-437D4595830A

The Blood Glucose Test Strips Market was valued at USD 5.91 billion in 2023, expected to reach USD 6.37 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 10.05 billion by 2030.

Blood Glucose Test Strips are pivotal in diabetes management, allowing individuals to monitor their blood sugar levels effectively. The scope of this market primarily encompasses healthcare applications, including personal use by diabetics and clinical settings. These strips are essential for diagnosing and managing diabetes, thus catering to a broad end-use scope ranging from hospitals and clinics to home care environments. The necessity of blood glucose test strips is underscored by the rising prevalence of diabetes globally, driven by factors like lifestyle changes, aging populations, and increasing incidences of obesity. Key growth factors include technological advancements such as the development of no-coding strips, increasing health awareness, and government initiatives promoting diabetes care. Moreover, expanding healthcare infrastructure across emerging markets offers an immense potential for growth. However, market expansion is hindered by factors such as pricing pressures, reimbursement issues, and stringent regulatory standards. Additionally, competition from continuous blood glucose monitoring systems poses a challenge. Opportunities abound in innovating user-friendly and minimally invasive testing solutions to enhance patient compliance and meet the growing demand for personalized medicine. Companies can invest in developing strips with advanced analytics capabilities integrated with digital health platforms for real-time monitoring and data analysis. Collaborations with digital health companies to offer comprehensive diabetes management solutions could also open new revenue streams. The market leans heavily towards innovation and research, suggesting that the integration of AI and IoT in product offerings could revolutionize disease management. Understanding patient needs and regulatory demands by engaging with stakeholders will be crucial for sustained growth. Businesses should focus on strategic partnerships and acquisitions to penetrate new markets effectively, ensuring a balance between innovation and cost-efficiency to maintain competitiveness in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 5.91 billion
Estimated Year [2024] USD 6.37 billion
Forecast Year [2030] USD 10.05 billion
CAGR (%) 7.86%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Glucose Test Strips Market

The Blood Glucose Test Strips Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
    • Awareness about diabetes preventive care
    • Guidelines for buying and using diabetes supplies
  • Market Restraints
    • High diabetes management costs
  • Market Opportunities
    • Proliferation of online product availability
    • Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
  • Market Challenges
    • Lack of accuracy in blood glucose test strips

Porter's Five Forces: A Strategic Tool for Navigating the Blood Glucose Test Strips Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Glucose Test Strips Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Glucose Test Strips Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Glucose Test Strips Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Glucose Test Strips Market

A detailed market share analysis in the Blood Glucose Test Strips Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Glucose Test Strips Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Glucose Test Strips Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Glucose Test Strips Market

A strategic analysis of the Blood Glucose Test Strips Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Glucose Test Strips Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, AgaMatrix, Inc., B. Braun Medical Ltd, Bayer AG, BioSensors, Inc., F. Hoffmann-La Roche Ltd, GlucoRx Limited, i-SENS Inc, LifeScan, Inc., National Diagnostic Products Pty Ltd, Nipro Diagnostics UK Limited, PHC Holdings Corporation, Spirit Healthcare, TaiDoc Technology Corporation, and Universal Biosensors Group.

Market Segmentation & Coverage

This research report categorizes the Blood Glucose Test Strips Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Channel Technology and Wicking Technology.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need an effective way to detect drastic changes in blood glucose for increasing diabetes cases
      • 5.1.1.2. Awareness about diabetes preventive care
      • 5.1.1.3. Guidelines for buying and using diabetes supplies
    • 5.1.2. Restraints
      • 5.1.2.1. High diabetes management costs
    • 5.1.3. Opportunities
      • 5.1.3.1. Proliferation of online product availability
      • 5.1.3.2. Potential in emerging economies in Asia due to huge diabetic population and increasing health spending
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of accuracy in blood glucose test strips
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Glucose Test Strips Market, by Technology

  • 6.1. Introduction
  • 6.2. Channel Technology
  • 6.3. Wicking Technology

7. Blood Glucose Test Strips Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Hospital Pharmacies
  • 7.3. Online Pharmacies
  • 7.4. Retail Pharmacies

8. Americas Blood Glucose Test Strips Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Blood Glucose Test Strips Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Blood Glucose Test Strips Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A. Menarini Diagnostics s.r.l
  • 2. AgaMatrix, Inc.
  • 3. B. Braun Medical Ltd
  • 4. Bayer AG
  • 5. BioSensors, Inc.
  • 6. F. Hoffmann-La Roche Ltd
  • 7. GlucoRx Limited
  • 8. i-SENS Inc
  • 9. LifeScan, Inc.
  • 10. National Diagnostic Products Pty Ltd
  • 11. Nipro Diagnostics UK Limited
  • 12. PHC Holdings Corporation
  • 13. Spirit Healthcare
  • 14. TaiDoc Technology Corporation
  • 15. Universal Biosensors Group

LIST OF FIGURES

  • FIGURE 1. BLOOD GLUCOSE TEST STRIPS MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GLUCOSE TEST STRIPS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GLUCOSE TEST STRIPS MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY CHANNEL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY WICKING TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BLOOD GLUCOSE TEST STRIPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. BLOOD GLUCOSE TEST STRIPS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. BLOOD GLUCOSE TEST STRIPS MARKET, FPNV POSITIONING MATRIX, 2023